Volume 38 Issue 8
Aug.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2022  >  38(8): 666-670
LU Yan, HUANG Huang. Evidence-Based Classic Formula Research on 'Formula-Disease-Person' and Empirical Exploration of TCM Academics[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(8): 666-670. doi: 10.14148/j.issn.1672-0482.2022.0666
Citation: LU Yan, HUANG Huang. Evidence-Based Classic Formula Research on "Formula-Disease-Person" and Empirical Exploration of TCM Academics[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(8): 666-670. doi: 10.14148/j.issn.1672-0482.2022.0666
shu

Evidence-Based Classic Formula Research on "Formula-Disease-Person" and Empirical Exploration of TCM Academics

doi: 10.14148/j.issn.1672-0482.2022.0666
  • 1.

    Oncology Center, Jiahui International Hospital, Shanghai 200233, China

  • 2.

    International Jingfang Institute, Nanjing University of Chinese Medicine, Nanjing 210023, China

  • Received Date: 2022-06-04
    Available Online: 2022-08-05
    Abstract
  • Evidence-based medicine is the only way for medical development, and the integration with evidence-based medicine is the urgent requirement for the development of traditional Chinese medicine (TCM). However, due to the unique academic characteristics of TCM, how to combine the TCM theories and practical experience with modern evidence-based research has become a difficult problem for the academic progress of TCM. Therefore, through regarding evidence-based research on the classic formula as a breakthrough, we explored the role and significance of combining TCM with evidence-based medicine in dealing with the relationship between syndrome differentiation and disease differentiation, in clarifying the efficacy, in treating new diseases and rare diseases, in the warning of adverse reactions, in the Chinese and western medicine interactions, in the empirical examination on the compatibility of medicines in prescriptions, as well as in the testing and optimization of traditional pharmaceutical methods. In conclusion, this study looks into the future of the evidence-based research on classic formula.

     

    • FullText(HTML)
  • loading
    • References(33)
  • [1]
    黄煌. 黄煌经方使用手册[M]. 北京: 中国中医药出版社, 2020: 1-3.

    HUANG H. Huang Huang's Guide to Clinical Application of Jingfang[M]. Beijing: China Press of Traditional Chinese Medicine, 2020: 1-3.
    [2]
    関矢信康, 林克美, 地野充時, 等. 半夏厚朴湯の使用目標の検討[J]. 日本東洋医学雑誌, 2007, 58(3): 481-485.

    SEKIYA N, HAYASHI K, CHINO A, et al. Investigation of clinical indications of hangekobokuto: Pain and sense of incongruity in Interscapular region[J]. Kampo Medicine, 2007, 58(3): 481-485.
    [3]
    八竹直, 金子茂男, 松浦健, 等. 前立腺肥大症の保存的療法——八味地黄丸の増量による臨床効果の検討および「証」と臨床効果の関係について[J]. 泌尿器科紀要, 1985, 31(3): 545-551.

    YACHIKU S, KANEKO S, MATSUURA T, et al. Conservative treatment of benign prostatic hypertrophy: Clinical effects of increased administration of Hachimijiogan and the relation between these effects and the "Sho" of Chinese medicine[J]. Hinyokika Kiyo, 1985, 31(3): 545-551.
    [4]
    BESSHO K, OKUBO Y, HORI S, et al. Effectiveness of Kampo medicine (Sai-boku-to) in treatment of patients with glossheartodynia[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology, 1998, 86(6): 682-686. doi: 10.1016/S1079-2104(98)90204-9
    [5]
    AZUSHIMA K, TAMURA K, HAKU S, et al. Effects of the oriental herbal medicine Bofu-tsusho-San in obesity hypertension: A multicenter, randomized, parall inel-group controlled trial (ATH-D-14-01021. R2)[J]. Atherosclerosis, 2015, 240(1): 297-304. doi: 10.1016/j.atherosclerosis.2015.01.025
    [6]
    ARAKAWA K, SARUTA T, ABE K, et al. Improvement of accessory symptoms of hypertension b y TSUMURA Orengedokuto Extract, a four herbal drugs containing Kampo-M and pharmacokineticedicine Granules for ethical use: A double-blind, peffect of Shengmai injection on serum concentrationlacebo-controlled study[J]. Phytomedicine, 2006, 13(1/2): 1-10.
    [7]
    TAKAYAMA S, ARITA R, OHSAWA M, et al. Perspectives on the use of ninjin'yoeito in modern medicine: A review of randomistudyzed controlled trials[J]. Evid Based Complement Alternat Med, 2019, 2019: 9590260. doi: 10.1155/2019/9590260
    [8]
    田中信. 蕁麻疹に対するClinicalオキサトミド (セルテクト) の臨床効果-オキサトミド30mg/dayとツムラ葛根湯の併用療法[J]. 薬理と治療, 1991(19): 5029-5031.

    TANAKA S. Clinical effect of oxatomide (Seltect) on urticaria - combination therapy of oxatomide (30 mg/day) with Tsumura Gegen decoction[J]. Pharm Therapy, 1991(19): 5029-5031.
    [9]
    LYU M, FAN GW, XIAO GX, et et al. Traditional Chinese medicine in COVID-19[J]. Acta Pharm Sin B, 2021, 11(11): 3337-3363. doi: 10.1016/j.apsb.2021.09.008
    [10]
    WANG ZL, YANG LY. Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts[J]. J Ethnopharmacol, 2021, 270: 113869. doi: 10.1016/j.jep.2021.113869
    [11]
    KANADA Y. A case of new-on set Vogt-koyanagi-harada disease successfully treated with the ryutanshakanto prepared at ikJY, kando and goreisan and no corticosteroids[J]. Nihon Toyo Igaku Zasshi, 2014, 65(4): 278-286. doi: 10.3937/kampomed.65.278
    [12]
    山崎武俊, 峯尚志, 土方康世. 動悸に対しMAOて小建中湯が有効であった虚証の4症例[J]. 日本東洋医学雑誌, 2015, 66(4): 331-336.

    YAMAZAKI T, MINE T, HIJIKATA Y. Four cases of palpitation with weak constitution successfully Treated with Shokenchuto[J]. Kampo Medicine, 2015, 66(4): 331-336.
    [13]
    津田笃太郎, 八代忍, 蒲生裕司, 等. ミクリッツ病における八味地黄丸のステロイド減量効果: 症例報告. 日本東洋医学雑誌, 2009, 60(5): 513-518. https://www.cnki.com.cn/Article/CJFDTOTAL-BQEB198002007.htm

    TSUDA T, YASHIRO S, GAMO Y, et al. Corticosteroid sparing effect of hachimijiogan in mikulicz's disease: A case report[J]. Kampo Med, 2009, 60(5): 513-518. https://www.cnki.com.cn/Article/CJFDTOTAL-BQEB198002007.htm
    [14]
    杉本精一郎, 松仓茂. 傷寒(5): 论阳明病篇の条文に関する一考察-Fisher症候群に対する大承气湯の使用経験[J]. 日本東洋医学雑誌, 2001, 52(2): 217-221. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJZH201202033.htm

    SUGIMOTO S, MATSUKURA S. A discussion on the text of the Yang disease stage in Shokan-ron-experience of the use of dai-joki-to for fisher syndrome[J]. Kampo Medicine, 2001, 52(2): 217-221. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJZH201202033.htm
    [15]
    志田圭三, 今村一男, 片山乔, 等. 各種泌2003, 尿器疾患に対する柴苓湯の臨床効果: 線維化疾患を中心として[J]. 泌尿器科紀要, 1994, 40(11): 1049-1057.

    SHIDA K, IMAMURA K, KATAYAMA T, et al. Clinical efficacy of saireito in various urinary tract diseases centering on fibrosis[J]. Hinyokika Kiyo, 1994, 40(11): 1049-1057.
    [16]
    NG AWT, POON SL, HUANG MN, et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia[J]. Sci Transl Med, 2017, 412(9): eaan6446.
    [17]
    MELCHART D, HAGER S, ALBRECHT S, et al. Traditional Chinese medicine and suspected liver injury: A prospective study[J]. World J Hepatol, 2017, 9(29): 1141-1157. doi: 10.4254/wjh.v9.i29.1141
    [18]
    WANG YJ, FENG F. Evaluation of the, hepatotoxicity of the Zhi-zi-Hou-Po Decoction by combining UPLC-Q-exactive-MS-based metabolom, ics and HPLC-MS/MS-based geniposide tissue distribution[J]. Molecules, 2019, 24(3): 511. doi: 10.3390/molecules24030511
    [19]
    HOMMA M, ISHIHARA M, QIAN W, et al. Effects of long term administration of Shakuyaku-kanzo-To and Shosaiko-To on serum potassium levels[J]. Yakugaku Zasshi, 2006, 126(10): 973-978. doi: 10.1248/yakushi.126.973
    [20]
    HIRAMATSU K, SAKATA H, HORITA Y, et al. Mesenteric phlebosclerosis associated with long-term oral intake of geniposide, an ingredient of herbal medicine[J]. Aliment Pharmacol Ther, 2012, 36(6): 575-586. doi: 10.1111/j.1365-2036.2012.05221.x
    [21]
    ENOMOTO YM, NAKAMURA YMP, ENOMOTO NMP, et al. Japanese herbal medicine-induced pneumonitis: A review of 73 patients[J]. Respir Investig, 2017, 55(2): 138-144. doi: 10.1016/j.resinv.2016.11.007
    [22]
    SU Q, LI YH. Interaction between warfarin and the herbal product Shengmai-yin: A case report of intracerebral hematoma[J]. Yonsei Med J, 2010, 51(5): 793-796. doi: 10.3349/ymj.2010.51.5.793
    [23]
    毛静远, 徐为人, 王恒和, 等. 生脉注射液对充血性心力衰竭患者地戈辛血药浓度和药动学参数的影响[J]. 中国中西医结合杂志, 2003, 23(5): 347-350. doi: 10.3321/j.issn:1003-5370.2003.05.008

    MAO JY, XU WR, WANG HH, et al. Clinical study on effect of Shengmai injection on serum concentration and pharmacokinetic parameters of digoxin in patients with congestive heart failure[J]. Chin J Integr Tradit West Med, 2003, 23(5): 347-350. doi: 10.3321/j.issn:1003-5370.2003.05.008
    [24]
    坂本第彦, 果山一道, 木下義见, 等. 肺小細胞癌に併発した低ナトリウム血症に五苓散が有効であった1例[J]. 日本東洋医学雑誌, 2015, 66(2): 124-130.

    SAKAMOTO A, KURIYAMA K, KINOSHITA Y, et al. A case of hyponatremia complicated with small cell lung cancer successfully treated with goreisan[J]. Kampo Medicine, 2015, 66(2): 124-130.
    [25]
    LIU SH, CHENG YC. Old formula, new Rx: The journey of PHY906 as cancer adjuvant therapy[J]. J Ethnopharmacol, 2012, 140(3): 614-623. doi: 10.1016/j.jep.2012.01.047
    [26]
    USHIROYAMA T, HOSOTANI T, MORI K, et al. Effects of switching to Wen-jing-Tang (unkei-to) from preceding herbal preparations selected by eight-principle pattern identification on endocrinological status and ovulatory induction in women with polycystic ovary syndrome[J]. Am J Chin Med, 2006, 34(2): 177-187. doi: 10.1142/S0192415X06003746
    [27]
    WANG ZY, KANDA S, SHIMONO T, et al. The in vitro estrogenic activity of the crude drugs found in Japanese herbal medicines prescribed for menopausal syndrome was enhanced by combining them[J]. BMC Complement Altern Med, 2018, 18(1): 107. doi: 10.1186/s12906-018-2170-4
    [28]
    李艺辉, 王丽莉, 于景献, 等. 炙甘草汤不同剂量及煎服方法对冠心病心律失常疗效观察[J]. 中国中西医结合杂志, 1994, 14(9): 552. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ409.017.htm

    LI YH, WANG LL, YU JX, et al. The effect of the different dosage and decoction method of Zhigancao decoction on the arrhythmia patients with coronary heart disease[J]. Chin J Integr Tradit West Med, 1994, 14(9): 552. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ409.017.htm
    [29]
    金汝真, 余仁欢, 高辉, 等. 五苓散与五苓汤治疗肾病综合征水湿内停证的临床对照研究[J]. 中医杂志, 2012, 53(7): 572-573, 577. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201207014.htm

    JIN RZ, YU RH, GAO H, et al. Comparative study of Wuling Powder and Wuling Decoction for nephrotic syndrome patients of water-damp collecting internally syndrome[J]. J Tradit Chin Med, 2012, 53(7): 572-573, 577. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201207014.htm
    [30]
    鳥居塚和生, 寺澤捷年, 本間精一, 等. 桂枝茯苓丸の製剤学的検討[J]. 日本東洋医学雑誌, 1985, 35(3): 185-189.

    TERASAWA K, MATSUDA H, IMADAYA A, et al. A study on clinical effects of Kuei-chih-fu-ling-wan prepared in the hospital pharmacy[J]. Kampo Medicine, 1985, 35(3): 185-189.
    [31]
    TIAN Q, LIU F, XU Z, et al. Evaluation of the chemical consistency of Yin-chen-hao-tang prepared by combined and separated decoction methods using high-performance liquid chromatography and quadrupole time-of-flight mass spectrometry coupled with multivariate statistical analysis[J]. J Sep Sci, 2019, 42(9): 1664-1675. https://pubmed.ncbi.nlm.nih.gov/30784184/
    [32]
    葛资宇, 童骄, 那婧婧, 等. 不同煎煮方法的麻杏石甘汤及其含药血清对A型流感病毒神经氨酸酶活性的影响[J]. 中国中西医结合杂志, 2016, 36(9): 1119-1123. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201609024.htm

    GE ZY, TONG J, NA JJ, et al. Effects of maxing Shigan Decoction decocted by different methods and its drug containing serum on neuraminidase activity of influenza A virus[J]. Chin J Integr Tradit West Med, 2016, 36(9): 1119-1123. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201609024.htm
    [33]
    小林匡子, 長冈佐知, 松山園美, 等. マゥスアミラーゼ阻害活性を利用した傷寒論における麻黄湯煎出手順の検討[J]. 日本東洋医学雑誌, 2008, 59(3): 477-482.

    KOBAYASHI K, NAGAOKA S, MATSUYAMA S, et al. Investigation of decoction procedure of maoto described in Shokan-ron using mouse amylase inhibitory activity[J]. Kampo Medicine, 2008, 59(3): 477-482.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (209) PDF downloads(39) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return